SOURCES SOUGHT
R -- Professional Staffing Supoort for BARDA
- Notice Date
- 12/27/2010
- Notice Type
- Sources Sought
- NAICS
- 541990
— All Other Professional, Scientific, and Technical Services
- Contracting Office
- Department of Health and Human Services, Office of the Secretary, Acquisitions Management, Contracts, & Grants (AMCG), Office of the Assistant Secretary for Preparedness & Response (ASPR), Department of Health and Human Services, 395 E Street, SW, Rm 1075.45, Washington, District of Columbia, 20024, United States
- ZIP Code
- 20024
- Solicitation Number
- BARDA-STAFF-2011
- Archive Date
- 1/25/2011
- Point of Contact
- Brendan Miller, Phone: 2022600962, Brian K Goodger, Phone: 202-260-0333
- E-Mail Address
-
brendan.miller@hhs.gov, Brian.Goodger@hhs.gov
(brendan.miller@hhs.gov, Brian.Goodger@hhs.gov)
- Small Business Set-Aside
- N/A
- Description
- This is a SMALL BUSINESS SOURCES SOUGHT NOTICE to determine the availability of small businesses (e.g., 8(a), veteran-owned small businesses, services-disabled veteran owned small businesses, HUB Zone small businesses, small disadvantaged businesses, and women-owned small businesses) having the capability to provide professional staffing support for the Biomedical Advanced Research & Development Authority (BARDA) within the Department of Health and Human Services (HHS), Office of the Secretary (OS), Office of the Assistant Secretary for Preparedness and Response. Small Businesses with the ability to meet the staffing needs BARDA has based on BARDA's mission (both included in the description) are encouraged to submit capability statements in response to this Source Sought. Description: The government has a need to acquire professional support in project management and technical subject matter expertise to the Biomedical Advanced Research and Development Authority (BARDA). These personnel will contribute to the BARDA's mission to provide medical countermeasures that address the public health medical consequences of chemical, biological, radiological, and nuclear (CBRN) events, pandemic influenza, and emerging infectious diseases. The Biomedical Advanced Research and Development Authority (BARDA) within the office of the Assistant Secretary for Preparedness and Response (ASPR) at the U.S. Department of Health and Human Services (HHS) located in Washington, D.C. has a mission to provide medical countermeasures that address the public health medical consequences of chemical, biological, radiological, and nuclear (CBRN) events, pandemic influenza, and emerging infectious diseases. BARDA was established by the Pandemic and All-Hazards Preparedness Act (PAHPA; PL 109-417), which was signed into law on December 19, 2006. Title IV of PAHPA established BARDA within HHS to coordinate the acceleration of medical countermeasure advanced research and development by collaborating with medical countermeasures developers and manufacturers, supporting advanced research and development, facilitating advice from the HHS Food and Drug Administration (FDA) and other regulatory bodies, and by supporting innovation in technologies and strategic initiatives (PAHPA, Title IV, Sec. 319L (4). BARDA uses a comprehensive portfolio approach to develop and acquire a broad array of medical countermeasures including vaccines, therapeutics, diagnostics, and non-pharmaceutical products. This approach includes coordination and co-management of medical countermeasure programs across HHS agencies and other USG agencies and with industry stakeholders through public - private partnerships. Additionally, the pandemic influenza program establishes national networks and Centers to provide and sustain domestic manufacturing infrastructure of these medical countermeasures. Since pandemics by their very nature as global epidemics are not just a domestic concern, BARDA supports USG global leadership and obligations through pandemic influenza programs that support the building of influenza vaccine manufacturing capacity in developing countries with direct funding and technical expertise. In the CBRN program, BARDA manages extramural programs that support advanced research and development and stockpiling acquisition of CBRN MCMs under Project BioShield including vaccines, antivirals and antibiotics, therapeutic antibodies, therapeutic proteins, peptides, and small molecules. The CBRN MCM portfolio includes candidates and products for smallpox, hemorrhagic fever viruses, anthrax, botulism, plague, tularemia, radiological and nuclear agents, nerve agents, and other biothreats. Additionally, the CBRN division conducts intramural studies with The National Institutes of Health (NIH), Centers of Disease Control and Prevention (CDC), and industry partners to develop animal models, improve product formulations and analytical testing. BARDA's Emerging Infectious Diseases program is currently developing a formal methodology to assess which emerging or re-emerging diseases should be incorporated into the BARDA portfolio. We will next assess MCM needs and gaps through interagency teams, "Blue Ribbon" expert panels, public outreach, and mathematical modeling to support the development of priorities. Through the experience of the 2009 H1N1 influenza pandemic, BARDA has recognized the role of its unique capabilities in a public health emergency response. In addition to supporting advanced development and procurement of MCMs, BARDA plans and establishes mechanisms for distributing MCMs during public health emergencies to complement and coordinate with CDC and ASPR assets and capabilities. The Contractor shall provide the following personnel to meet the requirements of the government. Background checks for conflict of interest(s) and ethics training for these positions will be essential for all persons connected with the Program(s) to ensure that no real or perceived ethical conflicts exist. The personnel proposed shall possess the required education, experience, and ability to obtain security clearances to perform under this requirement: The Contractor shall provide the following personnel to meet the requirements of the government. Background checks for conflict of interest(s) and ethics training for these positions will be essential for all persons connected with the Program(s) to ensure that no real or perceived ethical conflicts exist. The personnel proposed shall possess the required education, experience, and ability to obtain security clearances to perform under this requirement: • Project Managers (12); o Senior Project Manager (6) o Project Manager (6) • Subject Matter Experts (28); o Regulatory Affairs (6) o Clinical Studies (3) o Product Process Development (2) o Scale-up Manufacturing Facilities (2) o CBRN (9) o Medical diagnostic (2) o Small Molecule Drug Development (2) o Vaccine and Biologic Development (2) THIS SOURCES SOUGHT IS NOT AN RFP; an RFP is anticipated on or about January 13, 2011. This Sources Sought notice does not bind the government to release an RFP. A set-aside determination will be made based in part on the capabilities a firm is able to demonstrate in response to this Sources Sought. Responses to this Sources Sought announcement, along with a firm's capability statement referencing "Professional Staffing Support for BARDA - Capabilities" may be submitted to Brendan Miller, Contract Specialist at 202-260-0962 or in writing to Brendan.Miller@hhs.gov.
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/OOS/OASPHEP/BARDA-STAFF-2011/listing.html)
- Record
- SN02350730-W 20101229/101227233423-e60d9225653fdd84487c4d6b583f0cb6 (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |